A sacrococcygeal teratoma is a tumor that grows at the base of the tailbone, and it is the most common tumor found in newborns. Most are detected before birth on a routine ultrasound, appearing as a mass near the baby’s coccyx that can range from a small, barely noticeable lump to a growth larger than the baby itself. The word “teratoma” comes from the Greek for “monster” and “tumor,” reflecting the fact that these growths contain a bizarre mix of tissue types, including skin, hair, teeth, bone, and even nerve tissue. Despite their alarming appearance, the majority are benign and treatable with surgery, though the timing of diagnosis and treatment matters enormously for outcome.
Where the Tumor Comes From
Sacrococcygeal teratomas are thought to originate from a tiny cluster of cells called Hensen’s node, a structure that appears early in embryonic development and plays a key role in forming the body’s central axis and spinal column.1Surgery (Oxford). Sacrococcygeal teratoma Normally, Hensen’s node does its job and disappears. When remnant cells persist, they retain the ability to develop into virtually any tissue type. That is why a teratoma can contain such a strange assortment of mature tissues from all three embryonic germ layers. The tumor tends to anchor itself at the coccyx and can grow outward from the body, inward toward the pelvis, or both.
How Doctors Classify the Tumor
The Altman classification, developed by the American Academy of Pediatrics Surgical Section, groups sacrococcygeal teratomas into four types based on where the bulk of the mass sits relative to the body. Type I is mostly external, hanging from the tailbone area like a large protrusion. Type II has a dumbbell shape with roughly equal portions inside and outside the body. Type III is predominantly internal, with only a small external component. Type IV is entirely internal, hidden within the pelvis with nothing visible on the outside.2International Journal of Surgery Case Reports. Diagnosis and management of a sacrococcygeal teratoma at a tertiary hospital in northern Tanzania: A case report
The classification matters for more than just anatomy. Type I tumors are the easiest to spot on ultrasound and generally the most straightforward to remove surgically. Type IV tumors are the sneakiest: because they are entirely internal, they can go undetected until a child develops symptoms like constipation or difficulty urinating. They also tend to carry a higher risk of malignancy, in part because the delay in detection gives abnormal cells more time to change.
Prenatal Detection and Imaging
Most sacrococcygeal teratomas are discovered during a second-trimester ultrasound. Once a mass is spotted, doctors use fetal MRI to get a clearer picture. MRI can distinguish the different tissue components inside the tumor: solid tissue, fat, and fluid-filled cysts each produce distinct signals on the scan.3PubMed Central. Radiological features of sacrococcygeal teratomas in fetal magnetic resonance imaging and computed tomography That detail helps clinicians figure out whether the mass is mostly cystic, mostly solid, or a mix, because tumor composition influences both the treatment plan and the prognosis. Solid tumors tend to be more vascular and carry greater risk.
In one series of prenatal MRIs, most tumors were classified as Type II, with a mix of cystic and solid components being the most common appearance.4PubMed. Diagnosis and characterization of fetal sacrococcygeal teratoma with prenatal MRI MRI also reveals whether the tumor is compressing nearby structures like the bladder, rectum, or ureters, which is critical for planning both delivery and postnatal surgery. Getting the classification right before birth also helps distinguish a sacrococcygeal teratoma from other conditions that can look similar on ultrasound, such as a meningocele, where spinal membranes bulge outward through a defect in the spine.5PubMed Central. Sacrococcygeal Meningocele Antenatally Misdiagnosed as Teratoma: A Case Report
Why Large, Vascular Tumors Are Dangerous Before Birth
The biggest threat to a fetus with a sacrococcygeal teratoma is not the tumor itself but what it does to the baby’s heart. A highly vascular tumor acts like a sponge for blood flow, pulling large volumes of the baby’s cardiac output into the mass. This creates a vascular steal effect: the heart has to pump harder and harder to supply both the tumor and the rest of the body.6Journal of Diagnostic Medical Sonography. Sacrococcygeal Teratoma Eventually, the heart can fail from the overload, a condition called high-output cardiac failure. One well-documented case demonstrated the mechanism clearly: Doppler imaging showed enormous blood flow through the tumor, with massive enlargement of the vein returning blood to the heart, consistent with the tumor functioning as a large arteriovenous shunt.7Journal of Pediatric Surgery. Death due to high-output cardiac failure in fetal sacrococcygeal teratoma
When the heart starts failing, fluid accumulates throughout the baby’s body, a condition called hydrops. The placenta can also become massively enlarged. These are late-stage warning signs, and by the time they appear, the situation is often dire.
Predicting Which Babies Are at Greatest Risk
Doctors have identified several factors that help predict which fetuses will have the worst outcomes. A systematic review and meta-analysis found that signs of cardiac strain, including an enlarged heart, a highly vascular or predominantly solid tumor, hydrops, an enlarged placenta, and a high tumor-to-fetal-weight ratio, all predict poor outcomes.8PubMed. Prognostic accuracy of factors associated with poor outcome in prenatally diagnosed sacrococcygeal teratoma: A systematic review and meta-analysis
The tumor-volume-to-fetal-weight ratio, often abbreviated TFR, has become one of the most useful early warning tools. Research has found that when this ratio exceeds 0.12 before 24 weeks of pregnancy, the risk of a poor outcome rises sharply.9PubMed. Tumor volume to fetal weight ratio as an early prognostic classification for fetal sacrococcygeal teratoma A larger multi-center review confirmed this threshold, finding it predicted poor outcomes with high sensitivity and specificity.10PubMed. Predictors of poor prognosis in prenatally diagnosed sacrococcygeal teratoma: A multiinstitutional review In practical terms, a fetus whose tumor is growing rapidly relative to its body weight, especially before the sixth month of pregnancy, needs close monitoring and may be a candidate for fetal intervention.
Treating the Tumor Before Birth
For most fetuses with a sacrococcygeal teratoma, the plan is to deliver the baby and operate afterward. But for a small number of cases where the baby is developing heart failure too early for safe delivery, intervention before birth can be lifesaving. The options range from major open fetal surgery to less invasive needle-guided procedures.
Open fetal surgery involves partially exposing the uterus, accessing the tumor, and removing enough of it to relieve the strain on the baby’s heart. This is reserved for fetuses with signs of impending heart failure between roughly 20 and 30 weeks of pregnancy, when the baby is too premature to deliver safely. The goal during fetal surgery is not a complete cancer operation; it is to shrink the tumor enough to buy time, with the formal resection happening after birth.11PubMed Central. Fetal treatment of sacrococcygeal teratoma: state of the art
Minimally invasive approaches use needles inserted through the mother’s abdomen to target the blood vessels feeding the tumor. Radiofrequency ablation and laser ablation have both been used. An important early lesson was that ablating the bulk of the tumor tissue itself proved fatal in some cases; what works is targeting the major feeding vessels to cut off the tumor’s blood supply and relieve the heart’s burden.12PubMed. Radiofrequency ablation of human fetal sacrococcygeal teratoma In one series of laser ablations performed between 19 and 23 weeks, the procedure successfully eliminated visible blood flow within the tumor and improved heart function in all treated cases.13PubMed. Percutaneous Intratumor Laser Ablation for Fetal Sacrococcygeal Teratoma Survival rates across different minimally invasive techniques have varied widely, with radiofrequency ablation showing the best reported numbers and alcohol injection the worst, though the total number of cases treated worldwide remains small.14PubMed. Percutaneous Intratumor Laser Ablation for Fetal Sacrococcygeal Teratoma
Delivery and Surgery After Birth
How the baby is delivered depends largely on the tumor’s size. For smaller tumors under about five centimeters, vaginal delivery can be safe. For larger masses, cesarean delivery is strongly preferred to avoid the risk of the tumor rupturing during birth, which could cause life-threatening hemorrhage and difficult labor.15International Journal of Case Reports and Images. Successful cesarean delivery following prenatal diagnosis of giant sacrococcygeal teratoma in the fetus
Once the baby is stable, surgical removal of the tumor is the standard treatment. A critical detail of the operation is that the coccyx must be removed along with the tumor. Leaving the coccyx behind significantly increases the chance of recurrence, because residual totipotent cells embedded in the bone can regrow the tumor.16Surgery, Gastroenterology and Oncology. Outcomes of Sacrococcygeal Teratoma: An 18-year Experience in a Single Tertiary Referral Center in Thailand In one large study of recurrence factors, the most common tissue type found was mature teratoma, which is benign, but immature teratomas and malignant components like yolk sac tumors were also identified in a meaningful fraction of cases.17PubMed. Study of the factors associated with recurrence in children with sacrococcygeal teratoma
Malignancy and the Importance of Early Surgery
Most sacrococcygeal teratomas diagnosed at birth are benign. But the risk of malignancy climbs steeply with the child’s age at diagnosis. A large global retrospective study found that the probability of a malignant tumor at the time of initial surgery was about 3% at three months of age, roughly 5% at six months, around 10% at one year, and jumped to about 33% by age two. After age six, about two-thirds of newly diagnosed sacrococcygeal teratomas were malignant.18PubMed Central. Malignant transformation and tumour recurrence in sacrococcygeal teratoma: a global, retrospective cohort study This age-dependent pattern is one of the strongest arguments for early surgical removal. A tumor that might be entirely benign at birth can transform into a malignant germ cell tumor if left in place for months or years.
When a sacrococcygeal teratoma does turn out to be malignant, or when a recurrence contains malignant elements, chemotherapy becomes part of the treatment plan. The standard regimen is platinum-based, most commonly a combination of bleomycin, etoposide, and cisplatin (BEP).19PubMed Central. Adult sacrococcygeal teratoma: A review – Section: 1.4. Treatment of SCT An alternative regimen substituting carboplatin for cisplatin (JEB) is sometimes used in children.20PubMed Central. Malignant sacrococcygeal germ cell tumors in children in Taiwan Because sacrococcygeal teratomas with malignant components are relatively rare, treatment protocols have been adapted from what works for malignant ovarian germ cell tumors, which share similar biology.
Monitoring for Recurrence
Even after a complete resection of a benign-appearing tumor, recurrence is a real concern. Follow-up involves regular physical exams, imaging, and blood tests for alpha-fetoprotein (AFP), a protein that is normally elevated in newborns but should decline steadily after birth. A rising AFP level after it has normalized is a red flag for recurrent or malignant disease.21PubMed Central. Sacrococcygeal teratoma: evaluation of its approach, treatment and follow-up in two reference children cancer centers in Brazil / Rio de Janeiro
A systematic review of AFP’s accuracy as a surveillance tool found that about three-quarters of patients with recurrent sacrococcygeal teratomas had elevated AFP levels. When the analysis focused specifically on studies that tested AFP in all patients rather than just suspected recurrences, the sensitivity was about 79% and the specificity was 95%. For detecting malignant recurrence specifically, AFP’s sensitivity climbed to 96%.22PubMed. Diagnostic accuracy of serum alpha-fetoprotein levels in diagnosing recurrent sacrococcygeal teratoma: A systematic review AFP is not perfect as a screening test, and a normal level does not guarantee that a benign recurrence is not lurking, but a rising level is a strong signal that something needs immediate attention. Most centers continue AFP monitoring and periodic imaging for at least three years after surgery.
Long-Term Bladder and Bowel Function
Surviving the tumor and its removal is not the end of the story. Many children who had sacrococcygeal teratomas face lasting problems with bladder and bowel function. The tumor itself, its blood supply, and the surgery required to remove it can all damage the nerves that control the pelvic organs.
A UK nationwide study found that over a third of patients had documented bladder or bowel problems on long-term follow-up, with a significant fraction requiring ongoing medical management such as clean intermittent catheterization for the bladder or surgical procedures to manage bowel dysfunction.23PubMed. Sacrococcygeal teratoma: Long-term outcomes. A UK CCLG Surgeons Group Nationwide Study A controlled study comparing children who had sacrococcygeal teratomas to matched peers found significantly higher rates of uncontrolled voiding, difficulty emptying the bladder, kidney infections, and constipation in the teratoma group. Nearly half of the teratoma patients experienced constipation, compared to about one in seven in the control group. Children who had larger tumors and those with immature tissue types were more likely to have lasting functional problems.24PubMed. Long-Term Outcome of Sacrococcygeal Teratoma: A Controlled Cohort Study of Urinary Tract and Bowel Dysfunction and Predictors of Poor Outcome
Another study reported anorectal complications in about 29% of patients and urologic complications in about 33%, including neurogenic bladder, reflux of urine back toward the kidneys, and urinary incontinence.25Journal of Pediatric Surgery. Urologic and anorectal complications of sacrococcygeal teratomas: Prenatal and postnatal predictors These are not rare edge cases. Parents of a child treated for a sacrococcygeal teratoma should expect that long-term follow-up with urology and gastroenterology will likely be part of their child’s life, even when the tumor was fully benign and completely removed.
Mirror Syndrome and Risks to the Mother
The complications of a sacrococcygeal teratoma are not limited to the baby. When a fetus develops severe hydrops, the mother can develop a condition called mirror syndrome, in which her body begins to “mirror” the swollen state of the fetus and placenta. Symptoms resemble preeclampsia and can include rapid weight gain, swelling, high blood pressure, and fluid accumulation.26PubMed. Mirror syndrome associated with sacrococcygeal teratoma: a case report In some cases, the hormonal disruption can go further, with markedly elevated levels of pregnancy hormones triggering clinical hyperthyroidism in the mother, which adds complexity to anesthetic and surgical management.27PubMed. Anesthetic management of a parturient with fetal sacrococcygeal teratoma and mirror syndrome complicated by elevated hCG and subsequent hyperthyroidism
Mirror syndrome in the setting of a fetal sacrococcygeal teratoma carries a grave prognosis for the baby, but successful outcomes have been reported even in severe cases. One report documented the survival of a profoundly hydropic baby delivered at 27 weeks for maternal mirror syndrome, with the tumor successfully removed after birth.28PubMed. Survival of a profoundly hydropic fetus with a sacrococcygeal teratoma delivered at 27 weeks of gestation for maternal mirror syndrome Cases like these are valuable for families facing similar situations, because the combination of severe hydrops plus mirror syndrome might otherwise sound uniformly fatal.
The Connection to Currarino Syndrome
Most sacrococcygeal teratomas occur in isolation, without an identifiable genetic cause. But a small number occur as part of Currarino syndrome, a rare inherited condition defined by three features: a presacral mass (often a teratoma), an abnormally shaped sacrum, and an anorectal malformation.29PubMed Central. Currarino syndrome: a comprehensive genetic review of a rare congenital disorder Currarino syndrome is caused by mutations in a gene called MNX1, which plays a role in the development of the lower spine and spinal cord. In familial cases, the condition follows an autosomal dominant pattern, meaning a single copy of the mutated gene from one parent can cause the syndrome, though the severity varies widely even within the same family.30PubMed. Novel mutations in the MNX1 gene in two families with Currarino syndrome and variable phenotype
The variable presentation of Currarino syndrome means that some family members may have the full triad of features while others may have only a subtle sacral defect discovered incidentally. One report described a 26-year-old woman whose presacral teratoma led to the diagnosis of Currarino syndrome and the identification of a previously unreported MNX1 gene insertion.31PubMed. Presacral teratoma in a Curarrino syndrome woman with an unreported insertion in MNX1 gene Interestingly, MNX1 mutations are found in the vast majority of familial Currarino cases but in fewer than a third of sporadic ones, suggesting other genetic or developmental factors are involved.32PubMed Central. Currarino syndrome: a comprehensive genetic review of a rare congenital disorder For families with a known history of sacral anomalies or presacral masses, genetic testing for MNX1 can help identify at-risk relatives and guide screening.
Scars, Self-Image, and Quality of Life
One concern parents rarely hear about during the acute phase of diagnosis and surgery is how their child will feel about the scar years later. Because the incision is at the base of the spine and buttocks, it is hidden by clothing in nearly all situations. A study that measured quality of life and scar satisfaction in children who had undergone sacrococcygeal teratoma removal found reassuringly high scores. The median overall quality-of-life score was 94 out of 100, with strong results across physical, social, and school functioning. Seventy percent of the children said they never avoided situations because of their scar, and another 30% said they rarely did. A small number occasionally avoided tight clothing, and about one in five children felt moderately sad when thinking about the scar, but no children reported consistently avoiding activities or social situations because of it.33PubMed Central. Health-related quality of life and scar satisfaction in a cohort of children operated on for sacrococcygeal teratoma Many attributed their low distress to the scar’s discreet location. For parents bracing themselves for a difficult surgical journey, this is one area where the long-term news is genuinely encouraging.